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Aims: Regeneration in skeletal muscle relies on regulated myoblast migration and
differentiation, in which the transcription factor nuclear factor of activated T-cells
5 (NFAT5) participates. Impaired muscle regeneration and chronic inflammation are
prevalent in myositis. Little is known about the impact of inflammation on NFAT5
localization and expression in this group of diseases. The goal of this study was
to investigate NFAT5 physiology in unaffected myoblasts exposed to cytokine or
hyperosmolar stress and in myositis.
Methods: NFAT5 intracellular localization and expression were studied in vitro using
a cell culture model of myositis. Myoblasts were exposed to DMEM solutions enriched
with pro-inflammatory cytokines IFN-γ with IL-1β or hyperosmolar DMEM obtained by
NaCl supplementation. NFAT5 localization was visualized using immunohistochemistry
(IHC) and Western blotting (WB) in fractionated cell lysates. NFAT5 expression was
assessed byWB and RT-qPCR. In vivo localization and expression of NFAT5were studied
in muscle biopsies of patients diagnosed with polymyositis (n = 6), dermatomyositis
(n = 10), inclusion body myositis (n = 11) and were compared to NFAT5 localization and
expression in non-myopathic controls (n = 13). Muscle biopsies were studied by means
of quantitative IHC and WB of total protein extracts.
Results: In unaffected myoblasts, hyperosmolar stress ensues in NFAT5 nuclear
translocation and increased NFAT5 mRNA and protein expression. In contrast,
pro-inflammatory cytokines did not lead to NFAT5 nuclear translocation nor increased
expression. Cytokines IL-1β with IFN-γ induced colocalization of NFAT5 with histone
deacetylase 6 (HDAC6), involved in cell motility. In muscle biopsies from dermatomyositis
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and polymyositis patients, NFAT5 colocalized with HDAC6, while in IBM, this was often
absent.
Conclusions: Our data suggest impaired NFAT5 localization and expression in
unaffected myoblasts in response to inflammation. This disturbed myogenic NFAT5
physiology could possibly explain deleterious effects on muscle regeneration in myositis.
Keywords: NFAT5, myoblasts, hyperosmolar stress, pro-inflammatory cytokines, myositis
INTRODUCTION
Idiopathic inflammatory myopathies (IIM) are auto-
immune muscle diseases comprising polymyositis (PM),
dermatomyositis (DM), inclusion body myositis (IBM),
overlap myositis (OM), and immune mediated necrotizing
myopathy (IMNM) (Dalakas, 1991; Dalakas and Hohlfeld, 2003;
Hoogendijk et al., 2004; De Bleecker et al., 2013). These diseases
are characterized by chronic inflammation and presence of
pro-inflammatory cytokines. DM is a complement mediated
endotheliopathy whereas IBM and PM are cytotoxic T-cell
mediated diseases (De Bleecker and Engel, 1995). In IBM,
protein misfolding and autophagosome dysfunction do occur
(Benveniste et al., 2015). In IIM, affected muscle fibers suffer
necrosis (Loell and Lundberg, 2011). Attempts to regenerate
muscle tissue in IIM are compromised. Impaired proliferation
and altered fusion capacity has been described in primary cell
cultures from patients diagnosed with IIM (Cseri et al., 2015).
Skeletal muscle tissue regeneration occurs in five phases:
degeneration by necrosis, transient inflammation, regeneration,
remodeling, and functional repair (Musarò, 2014). After
activation, muscle stem cells become myoblasts, which will
fuse with damaged myofibers or with each other, forming new
myofibers (Hawke and Garry, 2001; Musarò, 2014). Transient
promyogenic inflammation is tightly regulated and perturbation
in the magnitude of the pro-inflammatory cytokines induces
chronic inflammation, which is deleterious to muscle repair.
One of the possible mechanisms explored in the past to explain
this effect is the activation of nuclear factor- B (NF- B) by
pro-inflammatory cytokines, interfering with the expression of
muscle proteins in differentiatingmyoblasts (Langen et al., 2001).
Nuclear factor of activated T-cells 5 (NFAT5) belongs to
the Rel family of transcription factors and is closely related to
NF- B (López-Rodríguez et al., 2001). It is expressed in skeletal
muscle, kidney cells, lymphocytes, thymus and testes (Miyakawa
Abbreviations: BLAST, Basic local alignment search tool; DM, dermatomyositis;
DMEMCyto, DMEM supplemented with pro-inflammatory cytokines IFN-γ +
IL-1β; DMEM18, DMEM enriched with NaCl, increasing osmolarity by 18mM;
DMEM60, DMEM enriched with NaCl, increasing osmolarity by 60mM; FITC,
fluorescein isothiocyanate; GAPDH, glyceraldehyde 3-phosphate dehydrogenase;
HDAC6, histone deacetylase 6; HSP70, heat shock protein 70; HSP90, heat shock
protein 90; IBM, inclusion body myositis; IF, immunofluorescence microscopy;
IFN-γ, interferon gamma; IIM, idiopathic inflammatory myopathies; IL-1β,
interleukin 1 beta; LTβ, lymphotoxin beta; MIQE, minimum information for
publication of quantitative real-time PCR experiments; NaCl, sodium chloride;
NCAM, neural cell adhesion molecule; NFAT5, nuclear factor of activated T-cells
5; PARP, poly (ADP-ribose) polymerase; PM, polymyositis; RT-qPCR, quantitative
real-time PCR; siRNA, silencing RNA; UMyo, unaffected myoblasts; WB, Western
blotting.
et al., 1998; López-Rodríguez et al., 1999; Trama et al., 2000).
Five different isotypes have been described for NFAT5: NFAT5a,
NFAT5b, NFAT5c, NFAT5d1, and NFAT5d2 (Eisenhaber et al.,
2011). Approximately half of endogenous NFAT5 under isotonic
conditions is isoform NFAT5a, attached to the plasma membrane
by palmitoylation and myristoylation. NFAT5b and NFAT5c are
diffusely present in the cytoplasm. In NFAT5a, only the plasma-
membrane bound fraction is sensitive to osmolar changes,
diffusing to the nucleus upon stimulation (Eisenhaber et al.,
2011). NFAT5 in general is tonicity sensitive in skeletal muscle
cells and is involved in myoblast migration and differentiation
(O’Connor et al., 2007). Cell motility and migration is regulated
by histone deacetylase 6 (HDAC6). Besides, NFAT5 regulates
heat-shock protein 90 (Hsp90), involved in IIM (Boyault et al.,
2007; Zhang et al., 2007; De Paepe et al., 2012).
In virtually all cells, maintaining cellular homeostasis is
met with nuclear translocation of NFAT5 and production of
organic osmolytes (Evans et al., 2009), restoring homeostasis
without disturbing cell function. The NFAT5 pathway can be
activated by osmotic shock or receptor activation, yielding a
different gene activation program (Kim N. H. et al., 2014).
Extracellular hypertonicity drains intracellular water to the
extracellular medium causing cell shrinkage (Lang et al., 1998)
and DNA damage. This is counteracted by electrolyte uptake
(i.e., regulatory volume increase) leading to high intracellular
ionic strength (Lang et al., 1998; Alfieri and Petronini, 2007).
The latter is neutralized by uptake and production of osmolytes
such as sorbitol, betaine and taurine (Brown, 1976, 1978; Lang
et al., 1998) after NFAT5 translocation to the nucleus (Ko et al.,
2000; Dahl et al., 2001). NFAT5 attempts to rescue osmolarity by
restoring cell volume and protecting DNA of incoming K+ and
Na+ ions (Ferraris et al., 1996; Miyakawa et al., 1998). NFAT5 is
an activator of tumor necrosis factor (TNF), lymphotoxin β (LTβ)
and heat shock protein 70 (HSP70) transcription (Woo et al.,
2002; Esensten et al., 2005; Creus et al., 2012). Both TNF-α, LTβ
and HSP70 are involved in IIM (De Bleecker et al., 1999; Creus
et al., 2012; De Paepe et al., 2012).
In this study we have hypothesized that there is impaired
NFAT5 localization and expression in myoblasts exposed to
pro-inflammatory cytokines IFN-γ with IL-1β since IIM are
characterized by chronic inflammation, deleterious to muscle
regeneration. In myoblasts exposed to hyperosmolar conditions,
we expect NFAT5 translocation to the nucleus and increased
NFAT5 protein expression. According to our hypothesis, we
expect impaired NFAT5 localization and expression in muscle
biopsies from patients diagnosed with IIM. Exploring the
putative colocalization of NFAT5 with HDAC6, involved in cell
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motility, in both myoblasts and muscle biopsies may further our
understanding of NFAT5’s cellular interactions in skeletal muscle
tissue under pro-inflammatory or hyperosmolar conditions.
MATERIALS AND METHODS
In Vitro Culture of Myoblasts from
Non-myopathic Individuals
Two primary myoblast cell cultures obtained from the Myobank
Banque D’ADN, France, were used for in vitro experimentation
and were kept under passage 12, to avoid cellular senescence.
Myoblasts obtained from unaffected individuals were labeled
“UMyo.” Hence, cell cultures UMyo1 and UMyo2 originated
from unaffected individuals (Supplementary Table 1). Consent
was obtained from all subjects and the study was approved by
local Ethic Committees. All cultures were grown in DMEM
containing glucose and 1% L-glutamine (Life technologies,
Carlsbad, USA), supplemented with 10% FCS (Cambrex,
Bioscience, Walkersville, USA), penicillin (50 IU/ml) +
streptomycin (50 mg/ml) (Gibco, Invitrogen, Carlsbad, USA)
(“DMEM”). Myogenicity was assessed in UMyo by IHC using an
antibody against CD56 (neural cell adhesion molecule, NCAM)
(Supplementary Table 2 and Supplementary Figure 1A, UMyo1).
UMyo7 and UMyo8 were obtained from the Laboratory
of Experimental and Clinical Neuroimmunology in Göttingen,
Germany. These cultures were grown in Skeletal Muscle Cell
Growth Medium + Supplement Mix (Promocell, Heidelberg,
Germany) at 37◦C and 5% CO2.
Exposure of Unaffected Myoblasts to
Pro-inflammatory Cytokines IFN-γ with
IL-1β or Hyperosmolar NaCl
Concentrations
UMyo1 and UMyo2 were transferred at 80% confluence to 8-
chamber slides for IHC studies and to 175-cm2 flasks with
DMEM for WB and RT-qPCR. Two 175-cm2 flasks were used
per condition to obtain sufficient amounts of cells for protein
and mRNA extraction. To mimic inflammatory conditions seen
in myositis, myoblasts were exposed to a mixture of pro-
inflammatory cytokines IFN-γ with IL-1β diluted in DMEM
to respective concentrations of 300 U/ml and 20 ng/ml (R&D
Systems, Minneapolis, USA) for 7 or 24 h (Schmidt et al., 2008).
Unstimulated myoblasts served as controls.
To examine the impact of differentiation on NFAT5
physiology in myoblasts, UMyo7 and UMyo8 were transferred to
8-chamber slides (LabTek II, Nunc, Penfield, USA) with DMEM
supplemented with 0.5% chick embryo extract (CEE, Accurate,
Westbury, USA). At 80% confluence, fusion was induced by
adding heat-treated horse serum for 48 h.
In DMEM, osmolarity was 110mM (280 mOsm/L) with a
NaCl concentration of 6.40 mg/ml. Preparing hyperosmolar
DMEM solutions was performed by adding 1.10 mg/ml NaCl,
to obtain an increase of 18mM, raising the concentration of
the solution to 128mM (333 mOsm/L). This solution is referred
to as “DMEM18” and corresponds to the change in osmolarity
after addition of cytokines to DMEM. Addition of 3.50 mg/ml
NaCl to DMEM to obtain an increase of 60mM of the solution,
resulted in a final osmolarity of 443 mOsm/L. The increase in
60mMwas based on Na+ concentrations in blood in the range of
135–145mM combined with the recent insight pointing to excess
salt intake as a worsening factor in autoimmune diseases (Sigaux
et al., 2017). This solution is designated as “DMEM60.” DMEM
supplemented with cytokine mixture IFN-γ with IL-1β displayed
an osmolarity of 339 mOsm/L and was labeled as “DMEMCyto.”
To study the impact of cytokines only, addition of DMEM18
(333 mOsm/L) to untreated cells yielded hyperosmolar controls.
This hyperosmolar condition was used as control to compensate
for the osmolar change induced in DMEMCyto. Osmolarity of
the media supplemented with NaCl or cytokines was measured
using an osmometer (Osmometer Automatic, Knauer, RS45105-
0, Berlin, Germany).
Patients
Diagnostic limb muscle biopsies (n = 27) were performed after
written informed consent had been obtained from patients or
their legal representatives with PM (n = 6), DM (n = 10), IBM
(n = 11) from the University Hospitals of Ghent and Antwerp
(Belgium) and the Institute of Neuropathology, RWTH Aachen
Medical School (Germany). All patients fulfilled the conventional
criteria for diagnosis (Dalakas and Hohlfeld, 2003; De Bleecker
et al., 2013). From the cryoblocks remaining after diagnostic
work-up, 6µm transversal sections were obtained for IHC and
protein extraction. PM is only diagnosed when non-necrotic
invaded muscle fibers are present in the diagnostic biopsy and
patients have reacted to immunotherapy. At the time of biopsy,
all patients were free of immunotherapy and all of them had
a progressive disease. The patients’ medical files were searched
for concomitant diseases (Supplementary Table 3). As NFAT5
is elevated in diabetic patients (Yang et al., 2006), this has to
be taken into account during the analysis of the results. The
same cautious approach is required if other autoimmune diseases
are present. Muscle biopsies from healthy individuals with no
clinical, electromyographic, or histologic evidence of myopathy
and free from any known other disease served as controls (n =
13). The study was approved by the Ghent University Hospital
Medical Ethics Committee and the RWTH Aachen Medical
School Ethics Committee.
Muscle Biopsies, Quantitative
Immunofluorescent Double and Triple
Staining, Confocal Microscopy, and Image
Analysis
Frozen 6µm transversal muscle tissue sections were used
for double immunofluorescence (IF) performed as described
previously (De Bleecker et al., 2002). Supplementary Table 2
summarizes antibodies and concentrations used during staining
for 1 h. Secondary staining was performed for 1 h with secondary
antibodies linked to the fluorescence markers AlexaFluor-
488 (green), FITC (green), AlexaFluor-555 (red) (Invitrogen,
Waltham, USA) or Cy3 (red) (Jackson ImmunoResearch
Laboratories West Grove, USA). Sections were imaged with
a Leica SP8 AOBS confocal microscope (Leica, Mannheim,
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Germany). Images were taken using a 63X HCX PL Apo 1.4
NA oil objective. Z-sections were made at the resolution limit,
in this case 126 nm, to produce a high-resolution stack suitable
for colocalization measurements. Images were acquired in a
sequential mode, scanned as 246 X 246 nm per pixel. To test for
antibody specificity, NFAT5 siRNA studies were completed. As
NFAT5 Rabbit yielded unspecific binding in myonuclei, NFAT5
Goat was selected as the antibody of choice (Supplementary
Figure 1B). NFAT5 Goat binds to all five NFAT5 isoforms.
Amino acid sequence analysis by BLAST (Basic Local Alignment
Search Tool, NIH, Bethesda, USA) of the NFAT5 Rabbit antibody
yielded recognition of two proteins, rendering the antibody
aspecific to NFAT5 (LLVSLQNQGN NLTGSF). The NFAT5
Goat was specific to NFAT5 (MPSDFISLLS ADLDLESPKS
LYSRESVYDL LPKELQLPPS RETSVASMSQ).
Quantitative Western Blotting (WB)
Total protein extracts were prepared from 175-cm² flasks
using appropriate lysis buffer (Laemmli 1x; 2-Mercaptoethanol
0.1%, Bromophenol Blue 0.01%, Glycerol 10%, SDS 2%, Tris-
HCl 60mM pH 6.8) followed by sonification. For patients’
biopsies, protein extracts were prepared by homogenizing frozen
muscle samples in 2 volumes of extraction buffer (50mM
TrisHCl, 2mM EDTA pH 7.4) supplemented with protease
inhibitor (TM mini protease inhibitor cocktail; Roche, Bazel,
Switzerland). To pellet debris, samples were centrifuged at
2,000 g for 10min. Proteins were transferred to nitrocellulose
membranes by electroblotting and incubated with primary
antibodies (Hendrix et al., 2010) (Supplementary Table 4)
and anti-GADPH (Abcam, Cambridge, Massachusetts, USA) to
correct for protein concentration between samples. PARP was
used as a nuclear control in WB of fractionated cell lysates
(BD Biosciences, Franklin Lakes, New Jersey, USA) and GAPDH
as a cytosolic marker. Immunoreaction was visualized using
chemiluminescence (WesternBrightTM Sirius, Advansta, Menlo
Park, California, USA) and Proxima 2650 (Isogen Life Science,
De Meern, The Netherlands).
In cell cultures, cell fractionation into nuclear and cytosolic
parts was performed by adding a hypotonic buffer (20mM
HEPES, 20% glycerol, 10mM NaCl, 1.5mM MgCl2, 0.2mM
EDTA, 0.1% Triton x-100 and MQ) for cell lysis. Nuclei were
separated into a pellet after gentle centrifugation at 800 rpm
for 10′. After resuspending the pellet in a hypertonic buffer (cf.
hypotonic buffer with 500mM NaCl instead of 10mM NaCl),
rotating it and spinning down, a supernatant containing the
nuclear fraction was obtained. NFAT5 antibody selectivity for
WB was assessed using siRNA NFAT5 (h): sc-43968 (Santa Cruz
Biotechnology, Santa Cruz, California, USA) in one cell culture
at 20 nM starting from a stock solution at 10µM. Scrambled
RNA (scRNA) was used as internal control for siRNA specificity.
ScRNA was prepared by diluting 2 µL in 2mL serum free
DMEM following the supplier’s protocol. Lipofectamine 2000
(Invitrogen) was used for transfection by diluting 75mL in 2mL
serum free DMEM followed by incubation for 5′ at RT. As
lipofectamine was produced in duplicate, each vial was added to
the respective siRNA and scRNA solutions and gently mixed for
20′ at RT. In one 75 cm2 flask with confluent layer, the siRNA
with lipofectamine was added. In the second 75 cm2 flask with
confluent layer, scRNAwith lipofectamine was added. Both flasks
were incubated for 24 h at 37◦C with 5% CO2. We used a DMEM
solution with an osmolarity increased to 135mMand results were
obtained by WB of total cell extractions.
RT-qPCR
One 175-cm2 flask per treatment condition was grown to
full confluency and cell cultures were exposed to cytokines
or hyperosmolar stress for 7 or 24 h. Total lysis of cell
cultures was obtained by following a well-described protocol
(Vandesompele et al., 2002) with a minimum purity of 1.9/2
measured by the A260/A280 ratio on BioDropTM Touch
Duo PC (Harvard Bioscience Inc., Holliston, Massachusetts,
USA). Results in line with the MIQE guidelines (Bustin
et al., 2009) were considered relevant after calculation with
qBase+ Software version 2.6 (www.qbaseplus.com) (Biogazelle,
Zwijnaarde, Belgium) (Hellemans et al., 2007). geNorm was used
to determine the most stable reference genes from a set of tested
candidate reference genes (Supplementary Table 5).
Statistical Analysis
For statistical analysis of quantitative confocal microscopy
images, the Mann Whitney U test was performed in SPSS 23.0
(IBM, Armonk, New York, USA), p < 0.05 were considered
statistically significant. The statistical analysis of colocalization
in confocal images was performed with Volocity 6.1.3 (Perkin
Elmer, Coventry, UK). Background levels were obtained by
measuring the voxel count of the signal outside the cells
and subtracted. Colocalization indexes M1 (NFAT5) and M2
(HDAC6) (which indicate the quantity of colocalization in
each individual channel), Mander’s Overlap coefficient (R)
and Pearson’s correlation coefficient (r) were calculated using
the appropriate algorithm in the Volocity software package.
Pearson’s correlation was solely chosen as a thresholding method
because measurements above background in both channels are
included in the calculations (Costes et al., 2004). M1 stands for
the quantity of red signal in the green channel, and M2 for the
quantity of green signal in the red channel. One-way ANOVA
with Tukey’s multiple comparison test was applied to the values
obtained from RT-qPCR analyzed by qBase+.
RESULTS
InUMyo,myoblast myogenicity was investigated by IHC. Double
IF staining withNFAT5 andNCAMyielded superposition of both
dyes after merging the immunofluorescent detection channels
(Supplementary Figure 1A).
All results described below were obtained in cell cultures
UMyo1 and UMyo2 where differentiation occurred by
spontaneous fusion, without any differentiation medium
(Supplementary Figure 2). In both cell cultures, myoblasts with
single myonuclei could be observed as well as nascent myotubes
harboring different myonuclei per cell, albeit to a lesser extent.
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NFAT5 Localization in Unaffected
Hyperosmolar Stressed Myoblasts
The impact of osmolar stress on NFAT5 localization was
studied in cultured myoblasts. Two primary myoblast cultures
from non-myopathic individuals (UMyo) were exposed to
hyperosmolar DMEM. NFAT5 localization was studied by IHC
and WB of fractionated cell lysates. In WB, PARP was used
as a marker for the nuclear fraction, GAPDH as a cytosolic
marker. Results are displayed in Figure 1. Variation in results
amongst different cell cultures are displayed in Supplementary
Figure 3.
By IHC and WB in UMyo1, NFAT5 was merely localized
in the cytoplasm of untreated myoblasts (n = 3). Exposure to
increasing hyperosmolar conditions showed a decrease in NFAT5
cytoplasmic staining (n = 3) and NFAT5 immunoreactivity in
the cytosolic fraction (n = 1). NFAT5 nuclear staining increased
(n = 3) along with NFAT5 immunoreactivity in the nuclear
fraction (n = 1). In WB specifically, PARP was merely expressed
in the nuclear fraction and GAPDH immunoreactivity was
mainly visible in the cytosolic compartment (Figure 1).
Variation in NFAT5 localization in UMyo was explored by
IHC after exposure to DMEM60. In all UMyo cultures, NFAT5
cytoplasmic staining appeared in a punctate pattern in untreated
conditions. NFAT5 nuclear staining was observed in all UMyo
after hyperosmolar stress (Supplementary Figure 3A). In UMyo7
and UMyo8, where DMEM was supplemented with heat-treated
horse serum, addition of heat-treated horse serum did not
influence NFAT5 localization as visualized in UMyo8 exposed to
DMEM18 or DMEM60 (Supplementary Figure 1C).
Impaired NFAT5 Nuclear Localization in
Unaffected Myoblasts Exposed to
Pro-inflammatory Cytokines IFN-γ with
IL-1β
The influence of cytokine stress on NFAT5 localization
was studied in cultured myoblasts. Two primary myoblast
cultures from non-myopathic individuals were exposed to
DMEM enriched with pro-inflammatory cytokine mixture IFN-
γ (300 U/ml) with IL-1β (20 ng/ml) (DMEMCyto). NFAT5
localization was studied by IHC and WB of fractionated cell
lysates. In WB, PARP was used as a marker for the nuclear
fraction, GAPDH as a cytosolic marker. To study the impact of
cytokines alone, addition of DMEM18 to untreated cells yielded
hyperosmolar controls. This hyperosmolar condition was used
as control to compensate for the osmolar change induced in
DMEMCyto. Results are displayed in Figure 2.
By IHC andWB in UMyo1, control myoblasts showed NFAT5
cytoplasmic and nuclear staining and NFAT5 immunoreactivity
in the cytosolic and nuclear compartments (cf. 3.1). In UMyo1
exposed to pro-inflammatory cytokines IFN-γ with IL-1β,
NFAT5 nuclear staining (n = 3) and immunoreactivity (n = 1)
were strongly decreased in almost all cells (Figure 2).
NFAT5 Expression in Unaffected Myoblasts
Exposed to Hyperosmolar or Cytokine
Stress
NFAT5 expression was studied by means of WB and RT-
qPCR. Firstly, RT-qPCR explored the presence of NFAT5 mRNA
FIGURE 1 | NFAT5 localization in unaffected myoblasts after 24 h exposure to hyperosmolar conditions. (A) Immunofluorescent staining was performed in UMyo1
(unaffected myoblasts) with NFAT5 Goat antibody, followed by a Cy3 (red)-labeled secondary antibody. Myonuclei were counterstained with DAPI staining (blue). White
arrows point at increased NFAT5 nuclear staining in UMyo1 exposed to DMEM18 or DMEM60 (DMEM with a total increase in osmolarity of 18 or 60mM) (n = 3).
(B) By WB, NFAT5 immunoreactivity increased in the nuclear fraction of UMyo1 after hyperosmolar stress. Cytosolic NFAT5 immunoreactivity decreased with
increasing hyperosmolar stress (n = 1).
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FIGURE 2 | NFAT5 localization in unaffected myoblasts after 24 h exposure to DMEM supplemented with pro-inflammatory cytokines IFN-γ with IL-1β.
(A) Immunofluorescent staining was performed in UMyo1 (unaffected myoblasts) with NFAT5 Goat antibody, followed by a Cy3 (red)-labeled secondary antibody.
Myonuclei were counterstained with DAPI staining (blue). NFAT5 nuclear staining was often absent in UMyo1 exposed to DMEMCyto (DMEM enriched with IFN-γ with
IL-1β). The white arrow points at increased NFAT5 nuclear staining in UMyo1 exposed to DMEM18 (DMEM with a total increase in osmolarity of 18mM) (n = 3). (B) By
WB, NFAT5 immunoreactivity decreased in the cytosolic and nuclear fraction of UMyo1 (n = 1).
after 7 and 24 h of exposure to cytokine or hyperosmolar
stress. Secondly, WB was performed on total cell lysates
exposed to hyperosmolar or cytokine stress for 24 h, to study
protein expression. The results are presented in Figure 3 and
Supplementary Figure 3B.
In UMyo1, a fold change in NFAT5 mRNA expression
of 7.04 (±1.53) (p < 0.001) was measured for NFAT5 after
7 h of exposure to DMEM60, with subsequent significant
increase in NFAT5 protein level (n = 3). Following conditions
yielded no significant increase in NFAT5 mRNA expression:
exposure for 24 h to DMEM60, 7 or 24 h exposure to
DMEMCyto. Exposure for 24 h to DMEMCyto had a
minor influence on NFAT5 protein expression (n = 3)
(Figure 3).
Variation in NFAT5 protein expression amongst cell
cultures was studied by WB of total cell lysates of
UMyo1 and UMyo2. DMEM60 increased significantly
NFAT5 protein expression (n = 3) (Supplementary
Figure 3B).
NFAT5 Colocalization with HDAC6 in
Unaffected Myoblasts Exposed to
Pro-inflammatory Cytokines IFN-γ with
IL-1β
By confocal microscopy, NFAT5 colocalization with HDAC6 was
studied in UMyo1 exposed to hyperosmolar or cytokine stress.
Colocalization of red and green dyes yielded a yellow to orange
signal. Colocalization was measured across the whole image by
Volocity and depicted in a diagram. Results are displayed in
Figure 4.
In UMyo1 exposed to DMEM18 or DMEM60, both red
(NFAT5) and green (HDAC6) signals were distinctly present
after superposition. Colocalization with HDAC6 was absent
(Figures 4A,C). Exposure to DMEMCyto induced NFAT5
colocalization with HDAC6, visible as a yellowish coloration
in the cytoplasm of the cells, after merging the red and green
detection channels. Displaying the colocalization indexes of
NFAT5 and HDAC6 in a graph after exposure to DMEM18,
DMEM60 or DMEMCyto yielded the same results (arrows,
Figures 4B,C).
NFAT5 Colocalizes with HDAC6 in PM and
DM, but Not in IBM
As visualized by IHC, 2/6 patients diagnosed with PM had a very
discrete, diffuse NFAT5 surface staining. In DM, similar features
were observed as in PM. In IBM, 4/8 patients expressed a positive
muscle fiber surface NFAT5 staining. In IIM, NCAM (CD56)
positive fibers (regenerating fibers) showed an absence of NFAT5
muscle fiber surface staining. The vast majority of inflammatory
cells were negative for NFAT5 in IIM biopsies (Figure 5A and
Supplementary Table 6).
By quantitative analysis of confocal microscopy images,
NFAT5 and HDAC6 colocalized in PM (p < 0.01) and DM
(p < 0.001), but not in IBM (Figures 5A,B). By WB of total
lysates of patients’ biopsies, NFAT5 was expressed in unaffected
individuals free of any disease, where NFAT5 expression ranged
from once to twice amount of NFAT5 protein. One individual was
randomly selected as the standard individual (black arrow) and
used in WB of PM, DM and IBM patients’ biopsies, allowing for
a comparison between blots. In PM, two out of three patients had
a NFAT5 protein expression similar to controls. One patient had
a decreased NFAT5 protein expression. In DM, NFAT5 protein
expression was in the same range as controls and only one
individual had no detectable levels of NFAT5 protein. In IBM,
two out of three patients had no detectable levels of NFAT5
protein (Figure 5C).
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FIGURE 3 | NFAT5 mRNA and protein expression in unaffected myoblasts exposed to hyperosmolar or pro-inflammatory conditions. (A) In UMyo1 (unaffected
myoblasts), exposure to DMEM60 for 7 h significantly increased NFAT5 mRNA expression (p < 0.001). In contrast, NFAT5 mRNA was not increased in UMyo1 after
24 h hyperosmolar treatment and after 7 or 24 h exposure to DMEMCyto (n = 3). Untreated UMyo1 were used as control. (B) By WB of total cell lysates, an increase
in NFAT5 protein levels was measured in UMyo1 after 24 h hyperosmolar challenge (n = 3).
Figure 6 presents a schematic overview of the obtained
results in NFAT5 physiology in unaffected myoblasts exposed to
hyperosmolar or cytokine enriched DMEM solutions.
DISCUSSION
This study describes two main findings in NFAT5 physiology
in unaffected muscle stem cells. Firstly, NFAT5 is translocated
to the myonuclei and upregulated in myoblast cell cultures
from unaffected individuals exposed to hyperosmolar DMEM
solutions. Specifically in DMEM with an osmolarity increased by
60mM,myoblasts display increased expression of NFAT5mRNA
and protein (IHC, WB, RT-qPCR). Secondly, after exposure of
unaffected myoblasts to DMEM supplemented with cytokines
IFN-γ with IL-1β, NFAT5 translocation to the myonuclei is
not detectable. Instead, NFAT5 colocalizes with HDAC6 in the
cytoplasm of myoblasts. NFAT5mRNA and protein levels are not
increased.
NFAT5 localization has been described in the past as being
merely nuclear in myoblasts, after staining with NFAT5 Rabbit
antibody for IHC (O’Connor et al., 2007). In the current
study, NFAT5 is merely localized in the cytoplasm of myoblasts
after staining with NFAT5 Goat for IHC. This observation
may be explained by NFAT5 antibody specificity. NFAT5 Goat
displays specific binding. NFAT5 staining is absent from both the
cytoplasm and the nucleus after siRNA NFAT5 studies. NFAT5
Rabbit seems to display aspecific binding in the nucleus and to a
lesser extend in the cytoplasm of myoblasts after siRNA NFAT5.
Our first observation corroborates with exposure of myoblasts
to mannitol, a membrane-impermeant osmotic protein, where
the NFAT5 reporter increases with increasing hyperosmolar
mannitol concentrations (O’Connor et al., 2007). In the present
study, adding hyperosmolar NaCl changes the cell environment
to a hyperosmolar stressful setting. This leads to water drainage
out of the cell by osmosis (Lang et al., 1998). To counteract
this deleterious effect, NFAT5 is activated and translocates to
the myonucleus where it binds with DNA (Ko et al., 2000; Dahl
et al., 2001), with subsequent upregulation of NFAT5 mRNA
and NFAT5 protein. NFAT5 is not colocalizing with HDAC6 in
this study. This may point to a normal NFAT5 physiology in
unaffected myoblasts after exposure to hyperosmolar conditions.
In the second observation, NFAT5 translocation could not be
detected in unaffected myoblasts triggered by DMEM enriched
with cytokines IFN-γ with IL-1β (IHC and WB). IFN-γ has
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FIGURE 4 | Study of NFAT5 colocalization with HDAC6 in unaffected myoblasts exposed to hyperosmolar or pro-inflammatory conditions. (A,B) Immunofluorescent
staining was performed in UMyo1 (unaffected myoblasts) with NFAT5 Goat antibody and HDAC6 antibody, followed respectively by a Cy3 (red)-labeled secondary
antibody and Alexa-488 (green)-labeled secondary antibody. Myonuclei were counterstained with DAPI staining (blue). NFAT5 with HDAC6 colocalization was only
observed in UMyo1 exposed for 24 h to DMEMCyto. Colocalization of red and green dyes yielded a yellow to orange signal (white arrow). (C) Colocalization
measurements were performed in UMyo1 by means of Volocity across all images. The graph represents colocalization indexes of NFAT5 and HDAC6 after exposure to
DMEM18, DMEM60 and DMEMCyto for 24 h. NFAT5 with HDAC6 colocalization was only observed in UMyo1 exposed for 24 h to DMEMCyto (white arrow) (n = 3).
been detected in muscle tissue of all the major subtypes of IIM
(Figarella-Branger et al., 2003; Preuße et al., 2012). IFN-γ, IL-
1β, and TNF-α were found to be markedly increased in IBM
muscle compared to PM and DM tissue (Schmidt et al., 2008).
Cytoplasmic NFAT5 was detected by IHC and WB, whereas
NFAT5 was absent from the nucleus both in IHC and WB.
By means of quantitative IHC, cytoplasmic NFAT5 colocalized
with HDAC6. In NFAT5 physiology, entry into the nucleus
depends of the nuclear localization system (NLS) localized in
an amino acid cluster with residues 202 to 204. Mutations
in this cluster abolish nuclear import of NFAT5 (Tong et al.,
2006). NFAT5 amino acid modifications have been described
for NFAT5, such as increased phosphorylation at threonine
135 (Gallazzini et al., 2011) or sumoylation after hyperosmolar
stress (Kim J. A. et al., 2014). In the current study, NFAT5
may not be able to translocate to the nucleus after cytokine
stimulation by alteration of the NLS or by conformational change
of NFAT5. In unaffected myoblasts, this might be a mechanism
to orchestrate the cell’s appropriate response to hyperosmotic vs.
pro-inflammatory conditions leading to a different downstream
factor activation scheme (De Paepe et al., 2016). NF- B is
upregulated in myoblasts after exposure to pro-inflammatory
cytokines. Under these conditions, it interferes with proteins
involved in myogenesis (Langen et al., 2001). In this study,
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FIGURE 5 | Study of NFAT5 localization and expression in control, PM, DM, and IBM biopsies (A,B) Immunofluorescent staining was performed in control, PM, DM,
and IBM biopsies with NFAT5 Goat antibody and HDAC6 antibody, followed respectively by a Cy3 (red)-labeled secondary antibody and Alexa-488 (green)-labeled
secondary antibody. Myonuclei were counterstained with DAPI staining (blue). In PM, and DM, NFAT5 colocalized with HDAC6, as displayed in the rectangular
subsets. This is visible as yellow structures next to the nucleus. Absence of NFAT5 colocalization with HDAC6 was noticed in IBM. By quantitative analysis of confocal
microscopy images, NFAT5 and HDAC6 colocalized in PM (p < 0.01) and DM (p < 0.001), but not in IBM. (C) By WB of total protein extraction of biopsies from
control individuals and patients diagnosed with PM, DM, and IBM, different NFAT5 protein levels were measured. PM merely displayed NFAT5 protein levels in the
same range as controls. In DM, 1/3 patients had no detectable NFAT5 protein levels. In IBM, 2/3 patients had no detectable levels of NFAT5 protein.
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FIGURE 6 | Schematic overview of NFAT5 localization and expression in unaffected myoblasts exposed to hyperosmolar or pro-inflammatory conditions. In
unaffected myoblasts under isotonic conditions, NFAT5 is located in the cytoplasm were it is attached to the plasma membrane and resides in the cytoplasm.
Increased osmolarity in these myoblasts induced NFAT5 translocation to the nucleus, with subsequent NFAT5 mRNA and protein level increase (upper myoblast). In
unaffected myoblasts exposed to pro-inflammatory cytokines IFN-γ with IL-1β, NFAT5 was not translocating to the nucleus and NFAT5 mRNA and protein level were
not increased (lower myoblast).
exposure of unaffected myoblasts to DMEM garnished with
IFN-γ+ IL-1β results in NFAT5 being localized in the cytoplasm
and colocalizing with HDAC6, possibly pointing to NFAT5
interacting with HDAC6. HDAC6 is involved in cell motility and
regulates heat shock protein 90 (Boyault et al., 2007; Zhang et al.,
2007). Besides, HDAC6 is downregulated in embryonic stem cells
during differentiation toward themyogenic cell lineage (Lee et al.,
2015).
By WB of fractionated cell extracts in UMyo, three bands for
NFAT5 are noticed, located around 170 kDa. In UMyo control
cells, two bands are located in the cytoplasmic compartment
and one band in the myonucleus. After hyperosmolar treatment,
the two bands located in the cytoplasmic fraction disappear.
The five following isotypes have been described for NFAT5:
NFAT5a, NFAT5b, NFAT5c, NFAT5d1, and NFAT5d2 obtained
by alternative splicing. Eisenhaber et al. (2011) describe diffusion
to the nucleus of the plasma-membrane bound fraction of
NFAT5a after exposure to salt stress of 350 mosm/L. This
condition induces nuclear translocation of all isoforms following
a linear curve with time, with complete migration to the nucleus
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of NFAT5b and NFAT5c (Eisenhaber et al., 2011). By consensus,
isoform NFAT5c has been chosen as the canonical sequence and
has a molecular weight of 166 kDa. Isoform NFAT5a weights
158 kDa (Germann et al., 2012). Isoform NFAT5b displays a
molecular weight of 11 kDa (Germann et al., 2012). NFAT5
isoforms d1 and d2, also called NFAT5z1 and NFAT5z2 or
NFAT5d and NFAT5e, have very similar molecular weights of
respectively 167.7 kDa and 167.8 kDa (Xiao et al., 2015).
NFAT5 is a key regulator of both myoblast migration and
differentiation during skeletal muscle myogenesis. Migratory
defects in NFAT5+/− myoblasts are described alongside a
decreased number of differentiated myoblasts during early
differentiation in dominant-negative NFAT5 cells (O’Connor
et al., 2007). Myofiber regeneration is a hallmark of DM and PM
and regeneration is known to be impaired in IBM (Morosseti
et al., 2006). Undetectable NFAT5 protein levels in almost all IBM
patients is noticed in this current study, when studying NFAT5
expression by WB.
Combination of cytokine with hyperosmolar NaCl, possibly
explaining the interplay between both conditions, led to complete
cell death and was not pursued.
In summary, we describe normal NFAT5 localization and
expression in unaffected myoblasts exposed to hyperosmolar
stress with NFAT5 translocation to the nucleus, increased NFAT5
mRNA and protein levels. In unaffected myoblasts exposed to
cytokine stress, NFAT5 localization and expression are impaired,
with NFAT5 mainly located in the cytoplasm. In PM and DM
patients’ biopsies, NFAT5 remains within the normal range,
whereas in IBM, an absence of NFAT5 expression can be seen.
As NFAT5 is a core protein to myogenesis, our findings may help
further our understanding of impaired muscle regeneration in
myositis.
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